Breaking News Instant updates and real-time market news.

2023-01-31 15:14:08 TKC Turkcell $4.94 / -0.16 (-3.14%) 15:14 01/31/23 01/31 15:14 01/31/23 15:14	Turkcell price target raised to TRY 43 from TRY 26.05 at JPMorgan JPMorgan analyst Jonathan Kennedy-Good raised the firm's price target on Turkcell to TRY 43 from TRY 26.05 and keeps a Neutral rating on the shares.

2023-01-31 15:14:08

TKC

Turkcell

$4.94 / -0.16 (-3.14%)

15:14

01/31/23

01/31

15:14

01/31/23

15:14

Turkcell price target raised to TRY 43 from TRY 26.05 at JPMorgan

JPMorgan analyst Jonathan Kennedy-Good raised the firm's price target on Turkcell to TRY 43 from TRY 26.05 and keeps a Neutral rating on the shares.

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks	ProQR announces initial pipeline targets, highlights Axiomer platfotform » 08:06 03/29/23 03/29 08:06 03/29/23 08:06 PRQR ProQR Therapeutics $3.58 / -0.02 (-0.56%) ProQR Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events PRQR ProQR Therapeutics $3.58 / -0.02 (-0.56%) 03/14/23 ProQR Therapeutics announces successful defense of Axiomer patent pending 03/07/23 ProQR Therapeutics to present on Axiomer RNA editing technology platform 12/22/22 Eli Lilly, ProQR expand genetic medicines licensing and collaboration agreement 12/22/22 Eli Lilly, ProQR Therapeutics to expand RNA editing collaboration PRQR ProQR Therapeutics $3.58 / -0.02 (-0.56%) 03/10/23 Stifel Stifel says SVB fallout 'appears limited' across firm's biotech coverage 12/28/22 Cantor Fitzgerald Cantor calls Merck top large cap pharma pick, names 8 SMID cap top picks 12/23/22 Raymond James ProQR Therapeutics price target raised to $5 from $2 at Raymond James 12/22/22 JMP Securities ProQR Therapeutics shares remain 'fairly valued,' says JMP Securities PRQR ProQR Therapeutics $3.58 / -0.02 (-0.56%) 11/09/22 ProQR Therapeutics reports Q3 EPS (EUR 0.34) vs (EUR 0.22) last year PRQR ProQR Therapeutics $3.58 / -0.02 (-0.56%) 12/22/22 Fly Intel: Pre-market Movers 10:00 Today ProQR Therapeutics - PRQR
Hot Stocks	EzFill and SaverOne 2014 launch driving safety pilot program in Florida » 08:06 03/29/23 03/29 08:06 03/29/23 08:06 SVRE SaverOne 2014 $1.15 / +0.02 (+1.77%) , EZFL EzFill / + EzFill (EZFL) announced a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings SVRE EZFL SVRE SaverOne 2014 $1.15 / +0.02 (+1.77%) 03/23/23 SaverOne 2014 signs agreement with Moviley Dror involving 150 delivery trucks 03/08/23 SaverOne 2014 signs agreement with Electra Afikim 01/19/23 SaverOne 2014's safe driving system adopted by Israeli supermarket Shufersal 01/17/23 SaverOne 2014 collaborating with Israeli auto importer for safe driving system EZFL EzFill / + 03/03/23 EzFill adds 10 fleet accounts in February 02/23/23 EzFill named Arbour to board of directors 02/21/23 EzFill signs agreement with South Florida Motorsports 01/30/23 EzFill to launch EzFill NOW Program EZFL EZFL EzFill / + 02/10/23 EzFill reports preliminary Q4 revenue $4.9M vs. $2M last year 11/08/22 EzFill reports Q3 EPS (15c) vs. (13c) last year
Earnings	Third Harmonic Bio reports 2022 EPS ($2.62), consensus ($2.39) » 08:06 03/29/23 03/29 08:06 03/29/23 08:06 THRD Third Harmonic Bio $4.30 / +0.02 (+0.47%) "Given the promising… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate On The Fly THRD Third Harmonic Bio $4.30 / +0.02 (+0.47%) 12/15/22 Third Harmonic Bio discontinues Phase 1b study of THB001 THRD Third Harmonic Bio $4.30 / +0.02 (+0.47%) 12/16/22 Jefferies Third Harmonic Bio downgraded to Hold from Buy at Jefferies 12/16/22 LifeSci Capital Third Harmonic Bio downgraded to Market Perform at LifeSci Capital 12/15/22 Morgan Stanley Morgan Stanley downgrades Third Harmonic after 'disappointing' discontinuation 12/15/22 Morgan Stanley Third Harmonic Bio downgraded to Equal Weight from Overweight at Morgan Stanley 15 Sep THRD Third Harmonic Bio $4.30 / +0.02 (+0.47%) 12/15/22 What You Missed On Wall Street On Thursday 12/15/22 What You Missed On Wall Street This Morning
Hot Stocks	Establishment Labs has surpassed three million Motiva devices in market » 08:05 03/29/23 03/29 08:05 03/29/23 08:05 ESTA Establishment Labs $68.73 / -1.89 (-2.68%) Establishment Labs… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly ESTA Establishment Labs $68.73 / -1.89 (-2.68%) 01/03/23 Establishment Labs enters Mia Femtech agreement in Japan 11/10/22 Establishment Labs announces Japan PMDA approval for Motiva Implants 10/19/22 Establishment Labs sinks 18% after Hindenburg short report ESTA Establishment Labs $68.73 / -1.89 (-2.68%) 01/24/23 Mizuho Establishment Labs price target raised to $95 from $70 at Mizuho 12/28/22 Stephens Establishment Labs price target lowered to $87 from $90 at Stephens 12/28/22 Stephens Cutera price target lowered to $68 from $78 at Stephens 10/21/22 B. Riley B. Riley sees 'major tailwind' for Establishment Labs in 2023 ESTA Establishment Labs $68.73 / -1.89 (-2.68%) 02/27/23 Establishment Labs reports Q4 EPS (55c), consensus (68c) 01/09/23 Establishment Labs reports preliminary Q4 revenue $43.3M-$44.4M 11/07/22 Establishment Labs narrows FY22 revenue view to $158M-$162M, consensus $160.5M 11/07/22 Establishment Labs reports Q3 EPS (76c), consensus (54c) ESTA Establishment Labs $68.73 / -1.89 (-2.68%) 10/19/22 Hindenburg shorts Establishment Labs, sees 90% long-term downside 10/19/22 Hindenburg Research announces short position in Establishment Labs ESTA Establishment Labs $68.73 / -1.89 (-2.68%) 03/10/23 Sell these stocks now, proven algorithm says 02/27/23 Fly Intel: After-Hours Movers 11/25/22 Sell these stocks now, proven algorithm says 10/19/22 What You Missed On Wall Street On Wednesday
Periodicals	FDIC taps Newmark to sell Signature Bank loans, WSJ reports » 08:05 03/29/23 03/29 08:05 03/29/23 08:05 SBNY Signature Bank $69.97 / + (+0.00%) , NMRK Newmark $6.46 / -0.04 (-0.62%) The FDIC has selected… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SBNY NMRK SBNY Signature Bank $69.97 / + (+0.00%) 03/27/23 FDIC investigating misconduct in management of SVB Financial, Signature Bank 03/22/23 Senators Scott, Warren unveil bipartisan Fed oversight legislation 03/22/23 Stronghold Digital reports no direct exposure to SVB, Signature, Silvergate 03/20/23 WhiteHorse Finance says no exposure to Silicon Valley Bank or Signature Bank NMRK Newmark $6.46 / -0.04 (-0.62%) 03/10/23 Newmark acquires real estate advisory firm, Gerald Eve, no terms disclosed 01/17/23 Frontier appoints Newmark to manage its real-estate portfolio 12/08/22 Newmark arranges $300M self storage joint venture 10/06/22 Newmark names Angie Leccese as chief marketing officer SBNY NMRK SBNY Signature Bank $69.97 / + (+0.00%) 03/24/23 Morgan Stanley nCino price target lowered to $27 from $35 at Morgan Stanley 03/22/23 BofA Regional bank distress gives CME Group a new growth opportunity, says BofA 03/22/23 Raymond James New York Community Bancorp resumed with a Strong Buy at Raymond James 03/20/23 BofA New York Community's Signature deal 'could be a significant positive,' says BofA NMRK Newmark $6.46 / -0.04 (-0.62%) 12/12/22 Goldman Sachs Newmark downgraded to Sell from Neutral at Goldman Sachs 10/07/22 Piper Sandler Newmark price target lowered to $10 from $12 at Piper Sandler 04/18/22 Piper Sandler Newmark downgraded to Neutral from Overweight at Piper Sandler 04/05/22 Goldman Sachs Newmark initiated with a Neutral at Goldman Sachs SBNY NMRK SBNY Signature Bank $69.97 / + (+0.00%) 01/17/23 Signature Bank reports Q4 EPS $4.65, consensus $4.89 10/18/22 Signature Bank reports Q3 EPS $5.57, consensus $5.41 10/17/22 Notable companies reporting before tomorrow's open 10/17/22 Notable companies reporting before tomorrow's open NMRK Newmark $6.46 / -0.04 (-0.62%) 02/16/23 Newmark sees FY23 revenue $2.5B- $2.7B, consensus $2.58B 02/16/23 Newmark sees Q1 revenue $500M-$550M, consensus $563.39M 02/16/23 Newmark reports Q4 adjusted EPS 32c, consensus 32c 10/28/22 Newmark lowers FY22 revenue view to $2.7B-$2.8B from $3.0B-$3.1B SBNY NMRK SBNY Signature Bank $69.97 / + (+0.00%) 03/26/23 Banking stress puts U.S., Europe on watch for credit crunch, Reuters says 03/21/23 $8T mortgage-debt market to be impacted after SVB collapse, WSJ reports 03/17/23 BofA not interested in acquiring Signature Bank, Reuters reports 03/17/23 FDIC open to sharing losses to smooth sale of SVB, Signature, FT says NMRK Newmark $6.46 / -0.04 (-0.62%) 02/15/23 Cushman & Wakefield commercial brokerage team heads to Newmark, WSJ says SBNY NMRK SBNY Signature Bank $69.97 / + (+0.00%) 03/20/23 What You Missed On Wall Street On Monday 03/20/23 What You Missed On Wall Street This Morning 03/17/23 Here's What You Missed in Crypto This Week 03/15/23 What You Missed On Wall Street On Wednesday NMRK Newmark $6.46 / -0.04 (-0.62%) 10/28/22 What You Missed On Wall Street This Morning 05/12/23 2023 Real Estate Summit 04/19/23 Signature Bank SBNY SBNY Signature Bank $69.97 / + (+0.00%) 03/20/23 Largest borrow rate increases among liquid names 03/09/23 Signature Bank put volume heavy and directionally bearish 01/18/23 Signature Bank put volume heavy and directionally bearish 01/18/23 Early notable gainers among liquid option names on January 18th
Downgrade	Maxim downgrades Monopar on termination of lead asset Validive » 08:05 03/29/23 03/29 08:05 03/29/23 08:05 MNPR Monopar Therapeutics $1.43 / -1.47 (-50.69%) Maxim analyst Jason… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings MNPR Monopar Therapeutics $1.43 / -1.47 (-50.69%) 03/27/23 Monopar Therapeutics Inc trading resumes 03/27/23 Monopar completes interim analysis of Phase 2b/3 VOICE trial 03/27/23 Monopar Therapeutics Inc trading halted, news pending 02/27/23 Monopar Therapeutics, NorthStar announces expanded radiopharma program MNPR Monopar Therapeutics $1.43 / -1.47 (-50.69%) 07:41 Today Maxim Monopar Therapeutics downgraded to Hold from Buy at Maxim 01/23/23 EF Hutton Monopar Therapeutics initiated with a Buy at EF Hutton 12/09/22 Roth Capital Monopar Therapeutics resumed with a Buy at Roth Capital 08/16/22 H.C. Wainwright Monopar Therapeutics price target lowered to $6 from $9 at H.C. Wainwright MNPR Monopar Therapeutics $1.43 / -1.47 (-50.69%) 03/23/23 Monopar Therapeutics reports Q4 EPS (22c), consensus (20c) 11/10/22 Monopar Therapeutics reports Q3 EPS (19c), consensus (22c)
Earnings	UniFirst sees 2023 EPS $5.02-$5.37, consensus $7.55 » 08:05 03/29/23 03/29 08:05 03/29/23 08:05 UNF UniFirst $192.81 / +1.12 (+0.58%) Sees revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events UNF UniFirst $192.81 / +1.12 (+0.58%) 02/08/23 UniFirst to acquire Clean Uniform for $300M 10/25/22 UniFirst increases quarterly common stock dividend to 31c per share UNF UniFirst $192.81 / +1.12 (+0.58%) 01/05/23 Baird UniFirst price target raised to $225 from $199 at Baird 05/18/22 Baird UniFirst price target lowered to $195 from $213 at Baird 04/01/22 JPMorgan UniFirst downgraded to sell on missed earnings pattern at JPMorgan 04/01/22 JPMorgan UniFirst downgraded to Underweight from Neutral at JPMorgan UNF UniFirst $192.81 / +1.12 (+0.58%) 08:03 Today UniFirst reports Q2 EPS 95c, consensus $1.38 01/04/23 UniFirst sees 2023 adjusted EPS $7.10-$7.50, consensus $7.21 01/04/23 UniFirst reports Q1 adjusted EPS $2.21, consensus $1.94 10/19/22 UniFirst sees 2023 adjusted EPS $7.10-$7.50, consensus $7.72 UNF UniFirst $192.81 / +1.12 (+0.58%) 01/04/23 What You Missed On Wall Street On Wednesday 01/04/23 What You Missed On Wall Street This Morning 09:00 Today UniFirst - UNF
Downgrade	Generation Income Properties cut to Hold at Maxim, no dividend coverage expected » 08:05 03/29/23 03/29 08:05 03/29/23 08:05 GIPR Generation Income Properties $4.75 / +0.07 (+1.50%) Maxim downgraded… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research GIPR Generation Income Properties $4.75 / +0.07 (+1.50%) 07:41 Today Maxim Generation Income Properties downgraded to Hold from Buy at Maxim
Earnings	Cocrystal Pharma reports FY22 ($4.77), consensus ($4.10) » 08:05 03/29/23 03/29 08:05 03/29/23 08:05 COCP Cocrystal Pharma $1.80 / -0.08 (-4.26%) "This is an eventful… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings COCP Cocrystal Pharma $1.80 / -0.08 (-4.26%) 12/19/22 Cocrystal reports safety, tolerability results from Phase 1 study of CC-42344 11/17/22 Cocrystal Pharma announces safety data from Phase 1 study with CC-42344 11/01/22 Cocrystal Pharma granted European patent covering CC-42344 10/26/22 Cocrystal Pharma completes enrollment in Phase 1 study of CC-42344 COCP Cocrystal Pharma $1.80 / -0.08 (-4.26%) 01/24/23 H.C. Wainwright Cocrystal Pharma price target lowered to $35 from $42 at H.C. Wainwright COCP Cocrystal Pharma $1.80 / -0.08 (-4.26%) 11/14/22 Cocrystal Pharma reports Q3 EPS (70c), consensus (48c)
Hot Stocks	Honeywell invests in Energy-as-a-Service provider Redaptive » 08:04 03/29/23 03/29 08:04 03/29/23 08:04 HON Honeywell $187.86 / -0.12 (-0.06%) Honeywell announced a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options HON Honeywell $187.86 / -0.12 (-0.06%) 03/14/23 Honeywell says Vimal Kapur to succeed Darius Adamczyk as CEO on June 1 03/14/23 Honeywell says Vimal Kapur to succeed Darius Adamczyk as CEO on June 1 02/06/23 TAT Technologies extends contract with global air carrier 02/02/23 Honeywell expects Q1 to be most supply constrained of the year HON Honeywell $187.86 / -0.12 (-0.06%) 02/28/23 UBS Honeywell price target lowered to $185 from $193 at UBS 02/14/23 HSBC Honeywell price target raised to $205 from $190 at HSBC 02/09/23 Credit Suisse Zebra Technologies downgraded to Neutral from Outperform at Credit Suisse 02/03/23 Deutsche Bank Honeywell price target lowered to $235 from $242 at Deutsche Bank HON Honeywell $187.86 / -0.12 (-0.06%) 02/02/23 Honeywell sees Q1 adjusted EPS $1.86-$1.96, consensus $2.03 02/02/23 Honeywell sees FY23 adjusted EPS $8.80-$9.20, consensus $9.13 02/02/23 Honeywell reports Q4 adjusted EPS $2.52, consensus $2.51 02/01/23 Notable companies reporting before tomorrow's open HON Honeywell $187.86 / -0.12 (-0.06%) 02/02/23 What You Missed On Wall Street On Thursday 02/02/23 What You Missed On Wall Street This Morning 02/02/23 Fly Intel: Pre-market Movers 01/04/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations HON Honeywell $187.86 / -0.12 (-0.06%) 01/18/23 Honeywell put volume heavy and directionally bearish

Earnings	UniFirst reports Q2 EPS 95c, consensus $1.38 » 08:03 03/29/23 03/29 08:03 03/29/23 08:03 UNF UniFirst $192.81 / +1.12 (+0.58%) Reports Q2 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events UNF UniFirst $192.81 / +1.12 (+0.58%) 02/08/23 UniFirst to acquire Clean Uniform for $300M 10/25/22 UniFirst increases quarterly common stock dividend to 31c per share UNF UniFirst $192.81 / +1.12 (+0.58%) 01/05/23 Baird UniFirst price target raised to $225 from $199 at Baird 05/18/22 Baird UniFirst price target lowered to $195 from $213 at Baird 04/01/22 JPMorgan UniFirst downgraded to sell on missed earnings pattern at JPMorgan 04/01/22 JPMorgan UniFirst downgraded to Underweight from Neutral at JPMorgan UNF UniFirst $192.81 / +1.12 (+0.58%) 01/04/23 UniFirst sees 2023 adjusted EPS $7.10-$7.50, consensus $7.21 01/04/23 UniFirst reports Q1 adjusted EPS $2.21, consensus $1.94 10/19/22 UniFirst sees 2023 adjusted EPS $7.10-$7.50, consensus $7.72 10/19/22 UniFirst reports Q4 adjusted EPS $1.79, consensus $1.73 UNF UniFirst $192.81 / +1.12 (+0.58%) 01/04/23 What You Missed On Wall Street On Wednesday 01/04/23 What You Missed On Wall Street This Morning 09:00 Today UniFirst - UNF
Hot Stocks	Curaleaf to acquire Deseret Wellness for $20M » 08:02 03/29/23 03/29 08:02 03/29/23 08:02 CURLF Curaleaf $2.95 / -0.0042 (-0.14%) Curaleaf Holdings… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly CURLF Curaleaf $2.95 / -0.0042 (-0.14%) 03/24/23 Curaleaf to delay Q4, FY earnings release, conference call 01/26/23 Curaleaf closes operations in California, Colorado and Oregon, cuts payroll 10% 01/24/23 Curaleaf expands Grassroots premium cannabis brand to New Jersey 01/12/23 Curaleaf opens Palm Beach Gardens dispensary CURLF Curaleaf $2.95 / -0.0042 (-0.14%) 02/08/23 Stifel Curaleaf price target lowered to C$8 from C$8.50 at Stifel 12/30/22 Cantor Fitzgerald Curaleaf price target lowered to $12 from $13 at Cantor Fitzgerald 12/01/22 Wedbush Wedbush starts Curaleaf with Outperform, expects share gains 12/01/22 Wedbush Curaleaf initiated with an Outperform at Wedbush CURLF Curaleaf $2.95 / -0.0042 (-0.14%) 11/07/22 Curaleaf reports Q3 EPS (7c), consensus (4c) CURLF Curaleaf $2.95 / -0.0042 (-0.14%) 01/26/23 Here's What You Missed in Cannabis, Psychedelics This Week 01/12/23 Here's What You Missed in Cannabis This Week 11/25/22 Rising High: Exclusive talk with cannabis REIT NewLake Capital
Hot Stocks	Spire CEO Suzanne Sitherwood retiring at year's end, board initiates CEO search » 08:02 03/29/23 03/29 08:02 03/29/23 08:02 SR Spire $69.22 / +0.06 (+0.09%) Spire CEO Suzanne… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly SR Spire $69.22 / +0.06 (+0.09%) 12/15/22 Spire says FERC determines Spire STL Pipeline needed on permanent basis SR Spire $69.22 / +0.06 (+0.09%) 02/07/23 Mizuho Spire price target raised to $73 from $69 at Mizuho 02/06/23 Stifel Stifel cuts Spire to Hold from Buy on valuation 02/06/23 Stifel Spire downgraded to Hold from Buy at Stifel 12/12/22 BofA Spire downgraded to Underperform at BofA following rebase of expectations SR Spire $69.22 / +0.06 (+0.09%) 02/01/23 Spire 'confident' in long-term ability to grow NEE per share 5%-7% 02/01/23 Spire raises FY23 NEE guidance to $4.15-$4.35, consensus $4.12 02/01/23 Spire reports Q1 NEE $1.55, consensus $1.05 12/02/22 Spire sees fiscal 2023 EPS $4.05-$4.25, consensus $4.25 SR Spire $69.22 / +0.06 (+0.09%) 02/07/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/05/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/16/22 What You Missed On Wall Street On Wednesday 11/16/22 What You Missed On Wall Street This Morning
Syndicate	PolyPid prices $6.2M public offering of common stock » 08:01 03/29/23 03/29 08:01 03/29/23 08:01 PYPD PolyPid / + PolyPid announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings PYPD PolyPid / + 02/08/23 PolyPid expects cash to fund operations 'well into' 3Q23 01/24/23 PolyPid provides regulatory update for D-PLEX100 01/03/23 PolyPid announces publication of Phase 2 clinical trial analysis of D-PLEX100 12/12/22 PolyPid schedules Type D meeting with FDA on SHIELD 1 Phase 3 results PYPD PolyPid / + 09/07/22 Barclays PolyPid downgraded to Equal Weight from Overweight at Barclays 09/06/22 Raymond James PolyPid downgraded to Outperform from Strong Buy at Raymond James 09/06/22 Raymond James PolyPid downgraded to Outperform from Strong Buy at Raymond James PYPD PolyPid / + 02/08/23 PolyPid reports Q4 EPS (32c), consensus (41c) 11/09/22 PolyPid reports Q3 EPS (48c), consensus (54c)
Options	Alibaba call buyer realizes 50% same-day gains » 08:00 03/29/23 03/29 08:00 03/29/23 08:00 BABA Alibaba $98.41 / +12.28 (+14.26%) Notable profits for the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options BABA Alibaba $98.41 / +12.28 (+14.26%) 03/28/23 Alibaba rises 12.4% 03/28/23 Alibaba to reorganize into six business groups and other investments 02/23/23 Alibaba jumps 6% to $100.65 after Q3 results beat estimates 02/23/23 Alibaba CEO sees 'continued recovery in consumer sentiment' BABA Alibaba $98.41 / +12.28 (+14.26%) 07:17 Today Loop Capital Alibaba shares offer event-driven upside, says Loop Capital 05:57 Today JPMorgan JPMorgan 'blue sky scenario' has Alibaba worth $210 per share 03/28/23 Truist Truist sees Alibaba reorganization driving accountability, shareholder value 03/28/23 Morgan Stanley Alibaba named 'Research Tactical Idea' at Morgan Stanley BABA Alibaba $98.41 / +12.28 (+14.26%) 02/23/23 Alibaba reports Q3 adjusted EPS $2.79, consensus $2.37 02/22/23 Notable companies reporting before tomorrow's open 02/22/23 Notable companies reporting before tomorrow's open 11/17/22 Alibaba reports Q2 adjusted EPS $1.82, consensus $1.64 BABA Alibaba $98.41 / +12.28 (+14.26%) 05:50 Today Alibaba reorganization triggers mass layoff fears, Nikkei Asia reports 03/28/23 Alibaba plans to split into six main units, explore IPOs, Bloomberg reports 03/27/23 Alibaba founder Jack Ma returns to China, Reuters reports 03/22/23 Part of Alibaba shareholder lawsuit dismissed by judge, Reuters reports BABA Alibaba $98.41 / +12.28 (+14.26%) 03/28/23 What You Missed On Wall Street On Tuesday 03/28/23 What You Missed On Wall Street This Morning 03/28/23 Fly Intel: Pre-market Movers 03/27/23 What You Missed On Wall Street This Morning BABA Alibaba $98.41 / +12.28 (+14.26%) 03/28/23 Unusually active option classes on open March 28th 03/24/23 Alibaba call volume above normal and directionally bullish 03/24/23 Unusually active option classes on open March 24th 03/23/23 Unusually active option classes on open March 23rd
Recommendations	Lululemon concerns 'haven't gone away' after Q4 report, says Jefferies » 07:58 03/29/23 03/29 07:58 03/29/23 07:58 LULU Lululemon $320.74 / +3.44 (+1.08%) Jefferies analyst Randal… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options LULU Lululemon $320.74 / +3.44 (+1.08%) 03/28/23 Lululemon jumps 9% to $348.97 after Q4 results, FY23 guidance beat estimates 01/12/23 lululemon teams with Nedap to advance RFID technology across stores 01/09/23 Lululemon falls 14% to $282.02 after revising Q4 guidance 12/08/22 Lululemon falls 9% to $340.75 after Q3 results and guidance LULU Lululemon $320.74 / +3.44 (+1.08%) 07:30 Today TD Cowen Lululemon price target raised to $500 from $470 at TD Cowen 07:20 Today Baird Lululemon price target raised to $425 from $410 at Baird 07:16 Today BofA Lululemon price target raised to $410 from $380 at BofA 07:03 Today JPMorgan Lululemon added to Analyst Focus List at JPMorgan LULU Lululemon $320.74 / +3.44 (+1.08%) 03/28/23 Lululemon sees FY23 EPS $11.50-$11.72, consensus $11.26 03/28/23 Lululemon sees Q1 EPS $1.93-$2.00, consensus $1.64 03/28/23 Lululemon reports Q4 adjusted EPS $4.40, consensus $4.26 03/28/23 Notable companies reporting after market close LULU Lululemon $320.74 / +3.44 (+1.08%) 09/30/22 Peloton tells Bloomberg resolved dispute with Lululemon over athletic wear 09/29/22 Peloton suit against Lululemon thrown out by court, Bloomberg reports 09/29/22 Lululemon wins dismissal of patent suit by Peloton, Bloomberg reports LULU Lululemon $320.74 / +3.44 (+1.08%) 03/28/23 Fly Intel: After-Hours Movers 03/18/23 Buy/Sell: Wall Street's top 10 stock calls this week 03/16/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/28/23 Buy/Sell: Wall Street's top 10 stock calls this week LULU Lululemon $320.74 / +3.44 (+1.08%) 03/28/23 Lululemon options imply 7.2% move in share price post-earnings 01/24/23 Unusually active option classes on open January 24th 01/04/23 Lululemon put volume heavy and directionally bearish 12/21/22 Unusually active option classes on open December 21st
Initiation	Jefferies starts Enliven with a Buy, $27 price target » 07:56 03/29/23 03/29 07:56 03/29/23 07:56 ELVN Enliven $23.52 / +0.515 (+2.24%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly Options ELVN Enliven $23.52 / +0.515 (+2.24%) 10/13/22 Imara to combine with Enliven Therapeutics in all-stock transaction ELVN Enliven $23.52 / +0.515 (+2.24%) 05:13 Today Jefferies Enliven initiated with a Buy at Jefferies 03/03/23 TD Cowen Enliven initiated with an Outperform at TD Cowen ELVN Enliven $23.52 / +0.515 (+2.24%) 03/03/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations ELVN Enliven $23.52 / +0.515 (+2.24%) 02/24/23 Four new option listings and one option delisting on February 24th
Downgrade	Penumbra cut to Hold at Needham on valuation » 07:53 03/29/23 03/29 07:53 03/29/23 07:53 PEN Penumbra $275.47 / -1.98 (-0.71%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly PEN Penumbra $275.47 / -1.98 (-0.71%) 01/25/23 Penumbra director sells $5.0M in common stock PEN Penumbra $275.47 / -1.98 (-0.71%) 05:48 Today Needham Penumbra downgraded to Hold from Buy at Needham 02/24/23 Needham Penumbra price target raised to $300 from $235 at Needham 02/24/23 Canaccord Penumbra price target raised to $286 from $246 at Canaccord 02/07/23 Deutsche Bank Penumbra price target raised to $297 from $250 at Deutsche Bank PEN Penumbra $275.47 / -1.98 (-0.71%) 02/23/23 Penumbra sees 2023 revenue $1B, consensus $1B 02/23/23 Penumbra reports Q4 non-GAAP EPS 16c, consensus 15c 11/03/22 Penumbra lowers FY22 revenue view to $840M-$845M from $860-$875 11/03/22 Penumbra reports Q3 EPS (6c), consensus 1c PEN Penumbra $275.47 / -1.98 (-0.71%) 10/12/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Recommendations	Amazon unlikely to acquire AMC, says Wedbush » 07:52 03/29/23 03/29 07:52 03/29/23 07:52 AMC AMC Entertainment $5.13 / +0.56 (+12.27%) , AMZN Amazon.com $97.27 / -0.84 (-0.86%) Wedbush says Amazon… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AMC AMZN AMC AMC Entertainment $5.13 / +0.56 (+12.27%) 03/14/23 CEO says AMC 'APE' conversion approved by shareholders 03/14/23 AMC falls after investors approve increase in common shares 03/14/23 AMC Entertainment trading resumes 03/14/23 AMC shares fall 10% amid shareholder votes at special meeting AMZN Amazon.com $97.27 / -0.84 (-0.86%) 03/28/23 Google teams with AI firm Replit to aid generative AI for software development 03/28/23 Semtech announces first LoRa-enabled third party products available 03/28/23 Lifeist's Mikra debuts on Amazon.com 03/24/23 User reports indicate problems at Amazon says Downdetector AMC AMZN AMC AMC Entertainment $5.13 / +0.56 (+12.27%) 03/28/23 Raymond James EPR has upside if AMC were to be sold, says Raymond James 03/23/23 Citi AMC Entertainment resumed with a Sell at Citi 02/09/23 Macquarie Macquarie raises price target on top theatre pick for 2023 01/30/23 B. Riley B. Riley sees APE unit vote opening 'massive' opportunity for AMC AMZN Amazon.com $97.27 / -0.84 (-0.86%) 06:46 Today KeyBanc Microsoft price target raised to $316 from $270 at KeyBanc 03/28/23 Raymond James EPR has upside if AMC were to be sold, says Raymond James 03/24/23 Barclays Meta Platforms price target raised to $270 from $260 at Barclays 03/21/23 Loop Capital Best Buy price gap relative to Amazon widens, says Loop Capital AMC AMZN AMC AMC Entertainment $5.13 / +0.56 (+12.27%) 02/28/23 AMC Entertainment reports Q4 adjusted EPS (14c), consensus (21c) 02/28/23 Notable companies reporting after market close 11/08/22 AMC Entertainment reports Q3 adjusted EPS (20c), consensus (25c) AMZN Amazon.com $97.27 / -0.84 (-0.86%) 02/02/23 Amazon sees Q1 revenue $121B-$126B, consensus $125.11B 02/02/23 Amazon reports Q4 EPS 3c with Rivian loss, consensus 17c 02/02/23 Notable companies reporting after market close 10/27/22 Amazon sees Q4 revenue $140B-$148B, consensus $155.15B AMC AMZN AMC AMC Entertainment $5.13 / +0.56 (+12.27%) 03/28/23 Amazon has 'NO deal on the table' for AMC Entertainment, FBN says 03/28/23 AMC Entertainment up after blog post speculation on Amazon interest 03/14/23 AMC shareholders approve 1-for-10 stock split, Bloomberg reports 03/14/23 AMC holders approve increase to common shares, Bloomberg reports AMZN Amazon.com $97.27 / -0.84 (-0.86%) 03/28/23 Amazon, Google will have to let U.K. radio stream on smart speakers, FT says 03/28/23 Amazon has 'NO deal on the table' for AMC Entertainment, FBN says 03/28/23 AMC Entertainment up after blog post speculation on Amazon interest 03/28/23 Disney eliminates metaverse unit, cutting 50 jobs, WSJ reports AMC AMZN AMC AMC Entertainment $5.13 / +0.56 (+12.27%) 03/28/23 What You Missed On Wall Street On Tuesday 03/23/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/28/23 Fly Intel: After-Hours Movers 12/28/22 What You Missed On Wall Street This Morning AMZN Amazon.com $97.27 / -0.84 (-0.86%) 03/28/23 What You Missed On Wall Street On Tuesday 03/26/23 Box Office Battle: ‘John Wick: Chapter 4’ opens with huge $73.5M 03/20/23 What You Missed On Wall Street On Monday 03/20/23 What You Missed On Wall Street This Morning 03/30/23 Enterprise IT AMC AMZN AMC AMC Entertainment $5.13 / +0.56 (+12.27%) 03/28/23 AMC Entertainment call volume above normal and directionally bullish 03/15/23 Notable open interest changes for March 15th 03/14/23 Largest borrow rate increases among liquid names 03/06/23 Largest borrow rate increases among liquid names AMZN Amazon.com $97.27 / -0.84 (-0.86%) 03/28/23 Notable open interest changes for March 28th 03/22/23 Notable open interest changes for March 22nd 03/07/23 Notable open interest changes for March 7th 03/03/23 Notable open interest changes for March 3rd
Recommendations	Piper Sandler price target lowered to $150 from $160 at Northland » 07:51 03/29/23 03/29 07:51 03/29/23 07:51 PIPR Piper Sandler $136.28 / -1.83 (-1.33%) Northland analyst Mike… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals PIPR Piper Sandler $136.28 / -1.83 (-1.33%) 03/24/23 Piper Sandler expands fixed income non-agency team with five hires 11/30/22 LPL Financial appoints Adam Turnquist as Chief Technical Strategist PIPR Piper Sandler $136.28 / -1.83 (-1.33%) 02/06/23 Northland Piper Sandler price target raised to $160 from $135 at Northland 02/06/23 JMP Securities Piper Sandler price target raised to $180 from $160 at JMP Securities 01/10/23 JMP Securities Piper Sandler price target lowered to $160 from $178 at JMP Securities 07/12/22 JMP Securities Piper Sandler price target lowered to $178 from $182 at JMP Securities PIPR Piper Sandler $136.28 / -1.83 (-1.33%) 02/03/23 Piper Sandler reports Q4 EPS $3.33, consensus $2.54 PIPR Piper Sandler $136.28 / -1.83 (-1.33%) 03/15/23 Piper Sandler tapped by FDIC to relaunch sale of SVB, Reuters reports

Recommendations	FGI Industries price target lowered to $4 from $5 at Northland » 07:50 03/29/23 03/29 07:50 03/29/23 07:50 FGI FGI Industries $2.13 / +0.19 (+9.79%) Northland lowered the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Earnings FGI FGI Industries $2.13 / +0.19 (+9.79%) 03/27/23 FGI Industries sees FY23 revenue $145M-$163M, two estimates $154.78M 03/27/23 FGI Industries reports Q4 EPS 7c vs. 15c last year
Recommendations	Walgreens Boots Alliance price target lowered to $40 from $42 at Truist » 07:49 03/29/23 03/29 07:49 03/29/23 07:49 WBA Walgreens Boots Alliance $33.81 / +0.855 (+2.59%) Truist analyst David… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options WBA Walgreens Boots Alliance $33.81 / +0.855 (+2.59%) 03/14/23 Senate Democrats urge Walmart, Kroger, others to sell mifepristone 03/06/23 Walgreens Boots Alliance to dispense Mifepristone where 'legally permissible' 03/06/23 California 'done' with Walgreens over abortion pill stance 03/02/23 Walgreens with DoorDash, Uber announce free Same Day Rx Delivery for HIV WBA Walgreens Boots Alliance $33.81 / +0.855 (+2.59%) 03/26/23 Barclays Walgreens Boots Alliance price target lowered to $43 from $45 at Barclays 03/22/23 Evercore ISI Walgreens Boots Alliance price target lowered to $35 from $36 at Evercore ISI 02/23/23 Loop Capital Loop Capital starts Walgreens Boots at Buy, sees higher growth from healthcare 02/22/23 Loop Capital Walgreens Boots Alliance initiated with a Buy at Loop Capital WBA Walgreens Boots Alliance $33.81 / +0.855 (+2.59%) 03/28/23 Walgreens Boots reaffirms FY23 adjusted EPS view $4.45-$4.65, consensus $4.51 03/28/23 Walgreens Boots Alliance reports Q2 adjusted EPS $1.16, consensus $1.10 03/27/23 Notable companies reporting before tomorrow's open 03/27/23 Notable companies reporting before tomorrow's open WBA Walgreens Boots Alliance $33.81 / +0.855 (+2.59%) 03/08/23 Walgreens stops offer abortion pill in 21 states, face blowback, NYTimes report 03/03/23 Walgreens will not distribute abortion pills in 20 states, Reuters report 01/25/23 Walgreens weighing sale of $2B pharmacy automation business, Bloomberg says 01/19/23 Rite Aid plans to provide abortion pill in some stores, Bloomberg reports WBA Walgreens Boots Alliance $33.81 / +0.855 (+2.59%) 03/28/23 What You Missed On Wall Street On Tuesday 03/28/23 What You Missed On Wall Street This Morning 03/28/23 Fly Intel: Pre-market Movers 03/06/23 What You Missed On Wall Street On Monday WBA Walgreens Boots Alliance $33.81 / +0.855 (+2.59%) 03/28/23 Unusually active option classes on open March 28th 03/27/23 Unusually active option classes on open March 27th 03/13/23 Walgreen Boots call volume above normal and directionally bullish 01/05/23 Unusually active option classes on open January 5th
Recommendations	Royal Caribbean price target lowered to $80 from $85 at Susquehanna » 07:49 03/29/23 03/29 07:49 03/29/23 07:49 RCL Royal Caribbean $61.86 / +1.38 (+2.28%) Susquehanna analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options RCL Royal Caribbean $61.86 / +1.38 (+2.28%) 02/07/23 Royal Caribbean jumps 5% to $72.54 after reporting Q4 results, FY23 guidance 02/07/23 Royal Caribbean sees FY23 CapEx $4.1B 02/07/23 Royal Caribbean 'very encouraged about the demand environment for 2023' 01/12/23 Royal Caribbean amends, extends revolving credit facilities RCL Royal Caribbean $61.86 / +1.38 (+2.28%) 03/23/23 Truist Royal Caribbean price target raised to $72 from $62 at Truist 02/08/23 Stifel Royal Caribbean price target raised to $90 from $86 at Stifel 02/08/23 Susquehanna Royal Caribbean price target raised to $85 from $62 at Susquehanna 02/08/23 Wells Fargo Royal Caribbean price target raised to $78 from $67 at Wells Fargo RCL Royal Caribbean $61.86 / +1.38 (+2.28%) 02/07/23 Royal Caribbean sees FY23 adjusted EPS $3.00-$3.60, consensus $3.25 02/07/23 Royal Caribbean sees Q1 adjusted EPS (85c)-(65c), consensus (80c) 02/07/23 Royal Caribbean reports Q4 adjusted EPS ($1.12), consensus ($1.34) 11/03/22 Royal Caribbean sees Q4 adjusted EPS ($1.50)-($1.30), consensus (67c) RCL Royal Caribbean $61.86 / +1.38 (+2.28%) 02/08/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/07/23 What You Missed On Wall Street On Tuesday 02/07/23 What You Missed On Wall Street This Morning 01/10/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations RCL Royal Caribbean $61.86 / +1.38 (+2.28%) 03/16/23 Unusually active option classes on open March 16th 03/15/23 Royal Caribbean put volume heavy and directionally bearish 02/07/23 Early notable gainers among liquid option names on February 7th 02/07/23 Unusually active option classes on open February 7th
Recommendations	PVH Corp. price target raised to $77 from $51 at Morgan Stanley » 07:48 03/29/23 03/29 07:48 03/29/23 07:48 PVH PVH Corp. $88.35 / +14.755 (+20.05%) Morgan Stanley raised the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options PVH PVH Corp. $88.35 / +14.755 (+20.05%) 03/28/23 PVH Corp. rises 19.2% 03/28/23 PVH Corp. rises 17.8% 03/28/23 PVH Corp. rises 13.7% 03/27/23 PVH Corp. jumps 10% to $80.80 after Q4 results, FY23 guidance beat estimates PVH PVH Corp. $88.35 / +14.755 (+20.05%) 07:44 Today Evercore ISI PVH Corp. price target raised to $100 from $60 at Evercore ISI 05:39 Today Barclays PVH Corp. price target raised to $110 from $106 at Barclays 03/28/23 Credit Suisse PVH Corp. price target raised to $93 from $87 at Credit Suisse 03/21/23 UBS PVH Corp. price target lowered to $92 from $100 at UBS PVH PVH Corp. $88.35 / +14.755 (+20.05%) 03/27/23 PVH Corp. sees FY23 EPS roughly $8.97, consensus $8.92 03/27/23 PVH Corp. sees Q1 EPS roughly $1.90, consensus $1.88 03/27/23 PVH Corp. reports Q4 adjusted EPS $2.38, consensus $1.67 11/30/22 PVH Corp. raises FY22 EPS view to $8.25 from $8, consensus $7.89 PVH PVH Corp. $88.35 / +14.755 (+20.05%) 03/28/23 What You Missed On Wall Street On Tuesday 03/28/23 What You Missed On Wall Street This Morning 03/28/23 Fly Intel: Pre-market Movers 03/27/23 Fly Intel: After-Hours Movers PVH PVH Corp. $88.35 / +14.755 (+20.05%) 03/27/23 PVH Corp. options imply 5.1% move in share price post-earnings
Periodicals	Icahn seeks to bring back Illumina's former CEO, WSJ reports » 07:48 03/29/23 03/29 07:48 03/29/23 07:48 ILMN Illumina $213.87 / -4.03 (-1.85%) Carl Icahn, who launched… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options ILMN Illumina $213.87 / -4.03 (-1.85%) 03/24/23 Illumina says Icahn nominees 'lack relevant skills and experience' 03/24/23 Icahn to investigate 'massive value destruction' by Illumina 03/20/23 Illumina says Icahn's nominees 'lack relevant skills and experience' 03/15/23 Icahn says 'only path forward' for Illumina is to divest GRAIL ILMN Illumina $213.87 / -4.03 (-1.85%) 03/13/23 Piper Sandler Piper agrees with Icahn, says Illumina base business undervalued 02/14/23 UBS Illumina price target lowered to $240 from $255 at UBS 02/08/23 Stifel Illumina price target lowered to $235 from $285 at Stifel 02/08/23 RBC Capital Illumina price target raised to $303 from $284 at RBC Capital ILMN Illumina $213.87 / -4.03 (-1.85%) 02/07/23 Illumina sees FY23 adjusted EPS $1.25-$1.50, consensus $1.98 02/07/23 Illumina reports Q4 adjusted EPS 14c, consensus 10c 02/07/23 Notable companies reporting after market close 11/03/22 Illumina sees FY22 adjusted EPS $2.35-$2.50, consensus $2.78 ILMN Illumina $213.87 / -4.03 (-1.85%) 03/13/23 Icahn planning proxy fight at Illumina, WSJ reports 01/11/23 Illumina to face EU fine of 10% of turnover due to Grail deal, Reuter says 01/11/23 Illumina facing EU fine of 10% turnover over Grail deal, Reuters says 10/08/22 Illumina should be bought before stock drives higher, Barron's says ILMN Illumina $213.87 / -4.03 (-1.85%) 03/13/23 What You Missed On Wall Street On Monday 03/13/23 What You Missed On Wall Street This Morning 03/13/23 Fly Intel: Pre-market Movers 02/07/23 Fly Intel: After-Hours Movers ILMN Illumina $213.87 / -4.03 (-1.85%) 03/13/23 Early notable gainers among liquid option names on March 13th 02/13/23 Early notable gainers among liquid option names on February 13th 02/07/23 Illumina options imply 6.4% move in share price post-earnings 10/04/22 Early notable gainers among liquid option names on October 4th

Events

Earnings calls, analyst events, roadshows and more

GLYC
Today at 08:30

GlycoMimetics - GLYC Conference Calls
MINM
Today at 08:30

Minim - MINM Conference Calls
BLUE
Today at 08:30

Bluebird Bio - BLUE Conference Calls
BTMD
Today at 08:30

Biote - BTMD Conference Calls
UNF
Today at 09:00

UniFirst - UNF Conference Calls
RDW
Today at 09:00

Redwire - RDW Conference Calls
BOSC
Today at 09:00

BOS Better Online Solutions - BOSC Conference Calls
IBEX
Today at 09:00

Ibex - IBEX Conference Calls
CLH
Today at 09:00

Clean Harbors Firm Sponsored Meetings

Virtual Meeting
PAYX
Today at 09:30

Paychex - PAYX Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	YGF X YGF YanGuFang IPO Managers: EF Hutton Priced at: $4.00 2M Shares ZJYL X ZJYL Jin Medical IPO Managers: Prime Number Priced at: $8.00 1M Shares
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	SYT X SYT Syla Technologies IPO Managers: Boustead $8.00 1.875M Shares
Fri	No deals

View All Syndicate Announcements »

Turkcell price target raised to TRY 43 from TRY 26.05 at JPMorgan

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access